Benzinga | Dec 9, 2021 09:46PM EST

Barclays Maintains Overweight on UiPath, Lowers Price Target to $61

Barclays analyst Raimo Lenschow maintains UiPath (NYSE:PATH) with a Overweight and lowers the price target from $71 to $61.